Donald P. Lawrence
- Oncology top 0.2%
- Molecular Biology top 2%
- Immunology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Genetics top 1%
- Co-authors
- Ryan J. SullivanKeith T. FlahertyF. Stephen HodiJustine V. CohenDavid F. McDermottAlexander T. FajeKerry L. ReynoldsOmid Hamid
- Topics
- Cancer Immunotherapy and Biomarkers (72 papers)Melanoma and MAPK Pathways (59 papers)CAR-T cell therapy research (43 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Donald P. Lawrence
154 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 6.7k
- Molecular Biology 3.1k
- Immunology 2.1k
- Pulmonary and Respiratory Medicine 1.8k
- Genetics 695
Countries citing papers authored by Donald P. Lawrence
This map shows the geographic impact of Donald P. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald P. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald P. Lawrence more than expected).
Fields of papers citing papers by Donald P. Lawrence
This network shows the impact of papers produced by Donald P. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald P. Lawrence. The network helps show where Donald P. Lawrence may publish in the future.
Co-authorship network of co-authors of Donald P. Lawrence
This figure shows the co-authorship network connecting the top 25 collaborators of Donald P. Lawrence. A scholar is included among the top collaborators of Donald P. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald P. Lawrence. Donald P. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 8 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 60 | |
| 10 | 48 | |
| 11 | 58 | |
| 12 | 5 | |
| 13 | 123 | |
| 14 | 76 | |
| 15 | 19 | |
| 16 | 97 | |
| 17 | 197 | |
| 18 | Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Functionbreakdown → | 574 |
| 19 | Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies | 4 |
| 20 | Thawing the Frozen Image/word: Vernacular Postmodern Aesthetics | 1 |
About Donald P. Lawrence
Donald P. Lawrence is a scholar working on Oncology, Immunology and Molecular Biology, having authored 161 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (72 papers), Melanoma and MAPK Pathways (59 papers) and CAR-T cell therapy research (43 papers). The work is most often cited by research in Oncology (6.7k citations), Immunology (2.1k citations) and Genetics (695 citations). Donald P. Lawrence has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Ryan J. Sullivan, Keith T. Flaherty, F. Stephen Hodi, Justine V. Cohen, David F. McDermott, Alexander T. Faje, Kerry L. Reynolds, Omid Hamid, Riley Fadden and Igor Puzanov. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.